Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fulcrum Therapeutics (FULC) Prepaid Assets: 2019-2024

Historic Prepaid Assets for Fulcrum Therapeutics (FULC) over the last 6 years, with Dec 2024 value amounting to $6.8 million.

  • Fulcrum Therapeutics' Prepaid Assets fell 20.93% to $5.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.2 million, marking a year-over-year decrease of 20.93%. This contributed to the annual value of $6.8 million for FY2024, which is 25.09% up from last year.
  • Latest data reveals that Fulcrum Therapeutics reported Prepaid Assets of $6.8 million as of FY2024, which was up 25.09% from $5.4 million recorded in FY2023.
  • Fulcrum Therapeutics' Prepaid Assets' 5-year high stood at $6.8 million during FY2024, with a 5-year trough of $4.1 million in FY2020.
  • In the last 3 years, Fulcrum Therapeutics' Prepaid Assets had a median value of $5.4 million in 2023 and averaged $5.5 million.
  • Data for Fulcrum Therapeutics' Prepaid Assets shows a peak YoY rose of 25.09% (in 2024) over the last 5 years.
  • Over the past 5 years, Fulcrum Therapeutics' Prepaid Assets (Yearly) stood at $4.1 million in 2020, then increased by 3.30% to $4.2 million in 2021, then rose by 4.05% to $4.4 million in 2022, then increased by 24.54% to $5.4 million in 2023, then increased by 25.09% to $6.8 million in 2024.